Completed

Robot Assisted vs Body Weight Supported Gait Training in Stroke Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

RoboGait

+ RehaWalk

+ Conventional

DeviceOther
Who is being recruted

Ischemic Stroke+5

+ Brain Diseases

+ Cardiovascular Diseases

Over 18 Years
+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: December 2023
See protocol details

Summary

Principal SponsorPamukkale University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: December 14, 2023

Actual date on which the first participant was enrolled.

This study focuses on evaluating the effectiveness of two different walking therapies for individuals who have experienced a stroke. Specifically, it aims to compare robotic-assisted gait training and treadmill training with body-weight support in helping stroke patients improve their walking abilities. Stroke can affect a person's ability to walk due to muscle weakness and impaired coordination. By comparing these therapies, researchers hope to identify which method better enhances movement and muscle activity in the legs, ultimately aiming to improve the quality of life for those affected by stroke. Participants in the study are divided into three groups. One group undergoes robotic-assisted gait training using a device called RoboGait, while another group receives treadmill training with body-weight support using RehaWalk. The third group engages in traditional walking exercises. The study measures changes in walking patterns and leg muscle activity to determine the effectiveness of each training method. Understanding the benefits and potential limitations of these therapies can lead to more effective treatment strategies for stroke rehabilitation.

Official TitleComparison of Robot Assisted Gait Training and Body Weight Supported Treadmill Training in Chronic Stroke Patients Using Gait Analysis and SEMG Measurements
NCT06715098
Principal SponsorPamukkale University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

45 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Ischemic StrokeBrain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersNervous System DiseasesVascular DiseasesStroke

Criteria

7 inclusion criteria required to participate
Age 18 and above

Chronic stage stroke (6 months - 2 years)

First stroke

Spasticity of Ashworth stage 2 or lower

Show More Criteria

4 exclusion criteria prevent from participating
Severe osteoporosis

Unstable fracture

Excessive spasticity (Ashworth stage 3 and above)

Cognitive impairment

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Robotic walking training 3 days a week, 30 minutes a day for 4 weeks

Group II

Experimental
Walking training on treadmill with body weight support for 30 minutes a day, 3 days a week for 4 weeks

Group III

Active Comparator
Conventional walking training for 30 minutes a day, 3 days a week for 4 weeks

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Pamukkale University

Denizli, Turkey (Türkiye)Open Pamukkale University in Google Maps
CompletedOne Study Center